159 related articles for article (PubMed ID: 31272065)
21. Antitumor efficacy of DNA vaccination to the epigenetically acting tumor promoting transcription factor BORIS and CD80 molecular adjuvant.
Loukinov D; Ghochikyan A; Mkrtichyan M; Ichim TE; Lobanenkov VV; Cribbs DH; Agadjanyan MG
J Cell Biochem; 2006 Aug; 98(5):1037-43. PubMed ID: 16741971
[TBL] [Abstract][Full Text] [Related]
22. Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.
Salmaninejad A; Zamani MR; Pourvahedi M; Golchehre Z; Hosseini Bereshneh A; Rezaei N
Immunol Invest; 2016 Oct; 45(7):619-40. PubMed ID: 27603913
[TBL] [Abstract][Full Text] [Related]
23. Identifying the Most Effective Hydatid Cyst Fluid Fraction for Anticancer Vaccination of 4T1 Breast Tumor-Bearing Mice.
Daneshpour S; Rostamirad S; Kefayat A; Mofid M; Safavi A; Darani HY
Int J Prev Med; 2019; 10():143. PubMed ID: 31516684
[TBL] [Abstract][Full Text] [Related]
24. Expression patterns of cancer testis antigens in testicular germ cell tumors and adjacent testicular tissue.
Yuasa T; Okamoto K; Kawakami T; Mishina M; Ogawa O; Okada Y
J Urol; 2001 May; 165(5):1790-4. PubMed ID: 11342977
[TBL] [Abstract][Full Text] [Related]
25. Active immunotherapy for mouse breast cancer with irradiated whole-cell vaccine expressing VEGFR2.
Yan HX; Cheng P; Wei HY; Shen GB; Fu LX; Ni J; Wu Y; Wei YQ
Oncol Rep; 2013 Apr; 29(4):1510-6. PubMed ID: 23404510
[TBL] [Abstract][Full Text] [Related]
26. Immunotherapy of experimental metastases by vaccination with interleukin gene-transduced adenocarcinoma cells sharing tumor-associated antigens. Comparison between IL-12 and IL-2 gene-transduced tumor cell vaccines.
Rodolfo M; Zilocchi C; Melani C; Cappetti B; Arioli I; Parmiani G; Colombo MP
J Immunol; 1996 Dec; 157(12):5536-42. PubMed ID: 8955204
[TBL] [Abstract][Full Text] [Related]
27. Mucosal vaccination with phage-displayed tumour antigens identified through proteomics-based strategy inhibits the growth and metastasis of 4T1 breast adenocarcinoma.
Shadidi M; Sørensen D; Dybwad A; Furset G; Sioud M
Int J Oncol; 2008 Jan; 32(1):241-7. PubMed ID: 18097564
[TBL] [Abstract][Full Text] [Related]
28. Increased immunogenicity of tumor vaccines complexed with anti-Gal: studies in knockout mice for alpha1,3galactosyltransferase.
LaTemple DC; Abrams JT; Zhang SY; Galili U
Cancer Res; 1999 Jul; 59(14):3417-23. PubMed ID: 10416604
[TBL] [Abstract][Full Text] [Related]
29. Effects of Combinatorial Ubiquitinated Protein-Based Nanovaccine and STING Agonist in Mice With Drug-Resistant and Metastatic Breast Cancer.
Huang F; Pan N; Wei Y; Zhao J; Aldarouish M; Wang X; Sun X; Wen Z; Chen Y; Wang L
Front Immunol; 2021; 12():707298. PubMed ID: 34589084
[TBL] [Abstract][Full Text] [Related]
30. Cancer/testis antigen CT45: analysis of mRNA and protein expression in human cancer.
Chen YT; Hsu M; Lee P; Shin SJ; Mhawech-Fauceglia P; Odunsi K; Altorki NK; Song CJ; Jin BQ; Simpson AJ; Old LJ
Int J Cancer; 2009 Jun; 124(12):2893-8. PubMed ID: 19296537
[TBL] [Abstract][Full Text] [Related]
31. Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy.
Lu M; Xia ZY; Bao L
Cell Immunol; 2013; 285(1-2):111-7. PubMed ID: 24177251
[TBL] [Abstract][Full Text] [Related]
32. Cancer-testis antigens: expression and correlation with survival in human urothelial carcinoma.
Sharma P; Shen Y; Wen S; Bajorin DF; Reuter VE; Old LJ; Jungbluth AA
Clin Cancer Res; 2006 Sep; 12(18):5442-7. PubMed ID: 17000678
[TBL] [Abstract][Full Text] [Related]
33. CIGB-247: a VEGF-based therapeutic vaccine that reduces experimental and spontaneous lung metastasis of C57Bl/6 and BALB/c mouse tumors.
Bequet-Romero M; Morera Y; Ayala-Ávila M; Ancizar J; Soria Y; Blanco A; Suárez-Alba J; Gavilondo JV
Vaccine; 2012 Feb; 30(10):1790-9. PubMed ID: 22240345
[TBL] [Abstract][Full Text] [Related]
34. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
35. Immunizing against breast cancer: a new swing for an old sword.
Curigliano G; Locatelli M; Fumagalli L; Goldhirsch A
Breast; 2009 Oct; 18 Suppl 3():S51-4. PubMed ID: 19914543
[TBL] [Abstract][Full Text] [Related]
36. Anticancer effectiveness of vaccination based on xenogeneic embryo proteins applied in different schedules.
Symchych TV; Fedosova NI; Karaman ОМ; Yevstratieva LM; Lisovenko HS; Voyeykova IM; Potebnia HP
Exp Oncol; 2015 Sep; 37(3):197-202. PubMed ID: 26422104
[TBL] [Abstract][Full Text] [Related]
37. Assessment of in vivo anti-tumor activity of human umbilical vein endothelial cell vaccines prepared by various antigen forms.
Zhou L; Si C; Li D; Lu M; Zhong W; Xie Z; Guo L; Zhang S; Xu M
Eur J Pharm Sci; 2018 Mar; 114():228-237. PubMed ID: 29277666
[TBL] [Abstract][Full Text] [Related]
38. Tumor antigens and markers for breast and ovarian cancers.
Ghadersohi A; Chitta K; Greco WR; Harvey S; Winston J; Slocum H; Odunsi K; Sood AK
Front Biosci; 2002 Feb; 7():e48-57. PubMed ID: 11815284
[TBL] [Abstract][Full Text] [Related]
39. Sperm-associated antigens as targets for cancer immunotherapy: expression pattern and humoral immune response in cancer patients.
Siliņa K; Zayakin P; Kalniņa Z; Ivanova L; Meistere I; Endzeliņš E; Abols A; Stengrēvics A; Leja M; Ducena K; Kozirovskis V; Linē A
J Immunother; 2011 Jan; 34(1):28-44. PubMed ID: 21150711
[TBL] [Abstract][Full Text] [Related]
40. Intravesical Bacillus Calmette Guerin Combined with a Cancer Vaccine Increases Local T-Cell Responses in Non-muscle-Invasive Bladder Cancer Patients.
Derré L; Cesson V; Lucca I; Cerantola Y; Valerio M; Fritschi U; Vlamopoulos Y; Burruni R; Legris AS; Dartiguenave F; Gharbi D; Martin V; Vaucher L; Speiser DE; Romero P; Jichlinski P; Nardelli-Haefliger D
Clin Cancer Res; 2017 Feb; 23(3):717-725. PubMed ID: 27521445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
